Abstract
To understand the clinical features, antimicrobial therapy, and epidemiology ofChryseobacterium indologenes infections, the medical records of 36 patients with nosocomialChryseobacterium indologenes infections seen over a three-year period at National Taiwan University Hospital were reviewed. The 36 isolates recovered from these patients were studied by molecular typing and determination of antimicrobial susceptibility patterns. Nine patients had underlying neoplastic diseases, seven had diabetes mellitus, five had burn wounds, and four had uremia. The clinical syndrome included ten patients with intraabdominal infections, nine with wound sepsis, six with intravascular catheter-related bacteremia, and four with ventilator-associated pneumonia. Thirteen patients had monomicrobial bacteremia, and four had polymicrobial bacteremia. Nineteen patients (53%) developed infections associated with various indwelling devices. The deaths of five patients (14%) were directly attributable to infection withChryseobacterium indologenes. All isolates recovered showed a wide range of resistance to commonly used antimicrobial agents. The random amplified polymorphic DNA (RAPD) patterns of the isolates differed from each other, indicating the absence of epidemiological relatedness among these isolates. Nosocomial infection caused by multiresistantChryseobacterium indologenes appears to be an emerging problem in Taiwan and should be studied further.
Article PDF
Similar content being viewed by others
References
Vandamme P, Bernardet JF, Segers P, Kersters K, Holmes B: New perspectives in the classification of the flavobacteria: description ofChryseobacterium gen. nov.,Bergeyella gen. nov., andEmpedobacter nom. rev. International Journal of Systematic Bacteriology 1994, 44: 827–831.
von Graevenitz A:Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative gram-negative bacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (ed): Manual of clinical microbiology. American Society for Microbiology, Washington DC, 1995, p. 520–532.
Stamm WE, Colella JJ, Anderson RL, Dixon RE: Indwelling arterial catheters as a source of nosocomial bacteremia: an outbreak caused byFlavobacterium species. New England Journal of Medicine 1975, 292: 1099–1102.
Pedersen MM, Marso E, Pickett MJ: Nonfermentative bacilli associated with man: III. Pathogenecity and antibiotic susceptibility. American Journal of Clinical Pathology 1970, 54: 178–192.
Sader HS, Jones RN, Pfaller MA: Relapse of catheter-relatedFlavobacterium meningosepticum bacteremia demonstrated by DNA macrorestriction analysis. Clinical Infectious Diseases 1995, 21: 997–1000.
Sheridan RI, Ryan CM, Pasternack MS, Weber JM, Tompkins RG: Flavobacterial sepsis in massively burned pediatric patients. Clinical Infectious Diseases 1993, 17: 185–187.
Ratner H:Flavobacterium meningosepticum. Infection Control 1984, 5: 237–239.
Bruun B, Jensen ET, Lundstrom K, Andersen GE:Flavobacterium meningosepticum infections in a neonatal ward. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 509–514.
Siegman-Igra Y, Schwartz D, Soferman G, Konforti N:Flavobacterium group llb bacteremia: report of a case and review ofFlavobacterium infections. Microbiology and Immunology 1987, 176: 103–111.
Yabuuchi E, Kaneko T, Yano I, Moss CW, Miyoshi N:Sphingobacterium gen. nov.,Sphingobacterium spiritivorum comb. nov.,Sphingobacterium multivorum comb. nov.,Sphingobacterium mizutae sp. nov., andFlavobacterium indologenes sp. nov.: glucose-nonfermenting, gram-negative rods in CDC group llk-2 and llb. International Journal of Systematic Bacteriology 1983, 33: 580–598.
Yabuuchi E, Hashimoto Y, Ezaki T, Ido Y, Takeuchi N: Genotypic and phenotypic differentiation ofFlavobacterium indologenes fromFlavobacterium gleum. Microbiology and Immunology 1990, 34: 73–76.
Bonten MJM, van Tiel FH, van der Geest S, Smeets HGW, Stobberingh EE, Gaillard CA: Topical antimicrobial prophylaxis of nosocomial pneumonia in mechanically ventilated patients: microbiological observation. Infection 1993, 21: 137–139.
Hsueh PR, Teng LJ, Ho SW, Hsieh WC, Luh KT: Clinical and microbiological characteristics ofFlavobacterium indologenes infections associated with indwelling devices. Journal of Clinical Microbiology 1996, 34: 1908–1913.
Hsueh PR, Hsiue TR, Hsieh WC: Pyomyositis in intravenous drug abusers: report of a unique case and review of the literature. Clinical Infectious Diseases 1996, 22: 858–860.
Hsueh PR, Hsiue TR, Wu JJ, Teng LJ, Ho SW, Hsieh WC, Luh KT:Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clinical Infectious Diseases 1996, 23: 550–555.
Pickett MJ: Methods for identification of flavobacteria. Journal of Clinical Microbiology 1989, 27: 2309–2315.
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2. NCCLS, Villanova, PA, 1993.
Dickinson GM, Bisno AL: Infections associated with indwelling devices: concepts of pathogenesis; infections associated with intravascular devices. Antimicrobial Agents and Chemotherapy 1989, 33: 597–601.
Salata RA, Lederman MM, Shlaes DM, Jacobs MR, Eckstein E, Tweardy D, Toossi Z, Chmielewski R, Marino J, King CH, Graham RC, Ellner JJ: Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. American Review of Respiratory Disease 1987, 135: 426–432.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RMH, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101: 1644–1655.
Holmes BR, Owen RJ, Steigerwalt AG, Brenner DJ:Flavobacterium gleum, a new species found in human clinical specimens. International Journal of Systematic Bacteriology 1984, 34: 21–25.
Verhasselt B, Claey G, Elaichouni A, Verschraegen G, Laureys G, Vaneechoutte M: Case of recurrentFlavimonas oryzihabitans bacteremia associated with an implanted central venous catheter (Port-A-Cath): assessment of clonality by arbitrarily primed PCR. Journal of Clinical Microbiology 1995, 33: 3047–3048.
Coyle-Gilchrist MM, Crewe P, Roberts G:Flavobacterium meningosepticum in the hospital environment. Journal of Clinical Pathology 1976, 29: 824–826.
Nathan P, Holder IA, MacMillan BG: Burn wounds: microbiology, local host defenses and current therapy. Critical Review of Clinical Laboratory Science 1983, 4: 61–78.
Pollack M:Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R (ed): Mandell, Douglas and Bennett's principles and practice of infectious diseases. Churchill Livingstone, New York, 1995, p. 1980–2003.
Aber RC, Wennersten C, Moellering RC Jr: Antimicrobial susceptibility of flavobacteria. Antimicrobial Agents and Chemotherapy 1978, 14: 483–487.
Strandberg DA, Jorgensen JH, Drutz DJ: Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrobial Agents and Chemotherapy 1983, 24: 282–286.
Jorgensen JH, Maher LA, Howell AW: Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli. Antimicrobial Agents and Chemotherapy 1991, 35: 2410–2414.
Raimondi A, Moosdeen FF, Williams JD: Antibiotic resistance pattern ofFlavobacterium meningosepticum. European Journal of Clinical Microbiology & Infectious Diseases 1986, 5: 461–463.
von Graevenitz A, Grehn M: Susceptibility studies onFlavobacterium ll-b. FEMS Microbiology Letters 1977, 2: 289–292.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hsueh, P.R., Teng, L.J., Yang, P.C. et al. Increasing incidence of nosocomialChryseobacterium indologenes infections in Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 16, 568–574 (1997). https://doi.org/10.1007/BF02447918
Issue Date:
DOI: https://doi.org/10.1007/BF02447918